140 Views | 117 Downloads
S.R.S. and C.D.J. contributed equally to this study.
Contribution: Z.R., S.R.S., and C.D.J. conceived of and wrote the manuscript; S.R.S., C.D.J., Z.R., M.S., and J.W. prepared the figures; A.L.S., H.V., C.L., M.G.Z., M.S., J.W., H.M., M.W., S.C., J.D.R., C.M.A., S.R.S., and C.D.J. critically reviewed, analyzed, and interpreted the data; M.G.Z., J.W., M.S., H.M., C.M.A., and S.R.S. performed the immunologic assays; and C.L. collected the donor units and information on blood donors.
Zahidee Rodriguez, Emory University, Children’s Healthcare of Atlanta–Egleston, 1405 Clifton Rd, 2nd Floor, Tower 1, Atlanta, GA 30322; e-mail: rodriquezz@kidsheart.com
The authors thank their colleagues at LifeSouth for collection of donor plasma. Parental consent was obtained for treatment with C19-CP. Review of medical records, publication of results, and research use of biospecimens per the Declaration of Helsinki under the protocols were approved by the Institutional Review Board of Emory University School of Medicine and the Department of Health and Human Services.
The authors declare no competing financial interests.
© 2020 by The American Society of Hematology